Skip to main content
Premium Trial:

Request an Annual Quote

Natera Prospera Kidney With Quantification

Natera has launched Prospera with Quantification, a cell-free DNA test for kidney rejection that provides the quantity of donor-derived cfDNA (dd-cfDNA), fraction of dd-cfDNA, and total cfDNA on every report. Combining these three metrics improves sensitivity when evaluating transplant rejection, compared to using dd-cfDNA fraction alone, Natera said. Currently, other commercially available cfDNA tests that assess transplant rejection only report the fraction of dd-cfDNA.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.